SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 298 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,355,290 | +98.6% | 66,030 | +88.5% | 0.49% | +89.1% |
| Q3 2022 | $1,186,000 | -63.2% | 35,026 | -35.0% | 0.26% | -49.3% |
| Q2 2018 | $3,227,000 | +36.8% | 53,910 | -8.6% | 0.51% | +62.1% |
| Q3 2017 | $2,359,000 | -28.6% | 58,967 | -23.1% | 0.31% | -42.5% |
| Q2 2017 | $3,305,000 | -7.0% | 76,692 | -46.6% | 0.55% | +14.5% |
| Q3 2016 | $3,553,000 | -7.4% | 143,679 | -23.7% | 0.48% | -17.3% |
| Q2 2016 | $3,835,000 | +20.5% | 188,277 | -20.5% | 0.58% | +38.7% |
| Q4 2015 | $3,183,000 | +5.4% | 236,833 | +10.0% | 0.42% | -13.0% |
| Q3 2015 | $3,020,000 | -35.0% | 215,265 | -21.3% | 0.48% | -12.0% |
| Q2 2015 | $4,644,000 | – | 273,517 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |